| Financial Year |
March 31 2023 |
| Monetary Funds |
212,068,033.13 |
| Held-for-trading Financial Assets |
30,099,750.00 |
| Notes Receivable |
60,222.00 |
| Accounts Receivable |
55,611,928.31 |
| Advances to Suppliers |
18,149,919.03 |
| Other Receivables |
19,078,145.53 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
83,337,947.31 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
153,343,154.95 |
| Total Current Assets |
571,749,100.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
192,039,105.64 |
| Investment Properties |
-- |
| Fixed Assetes |
83,751,948.56 |
| Under-construction Projects |
203,798,319.54 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
41,928,935.00 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
10,978,611.32 |
| Deferred Income Tax Assets |
20,369,798.78 |
| Other Non-Current Assets |
33,572,204.71 |
| Sub-Total of Non-Current Assets |
631,158,729.22 |
| Total Assets |
1,202,907,829.48 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
63,061,338.39 |
| Accounts Received In Advance |
83,595.29 |
| Employee Compensation Payable |
16,462,662.78 |
| Taxes Payable |
7,628,555.52 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,135,304.53 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
24,176,402.89 |
| Other Current Liabilities |
1,716,766.07 |
| Sub-Total of Current Liabilities |
147,639,422.25 |
| Long-term Loans |
56,232,830.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,080,000.00 |
| Deferred Income Tax Liabilities |
108,506.86 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
114,521,406.20 |
| Total Liabilities |
262,160,828.45 |
| Paid-In Capital(Or Share Stock) |
400,860,000.00 |
| Capital Surplus |
182,009,649.07 |
| Surplus Reserve |
53,580,647.83 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
303,789,021.50 |
| Minority Stockholder's Interest |
-185,766.85 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
940,932,767.88 |
| Owner's Equity（Stockholder's Equity） |
940,747,001.03 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,202,907,829.48 |
